Key result
Conduction system pacing with AV node ablation shows similar major event rates to PVI in persistent AF.
Why the study?
Conduction system pacing with atrioventricular node ablation is a feasible option for symptomatic AF, but comparative studies with pulmonary vein isolation are limited.
Does conduction system pacing combined with atrioventricular node ablation improve clinical outcomes compared to pulmonary vein isolation in patients with persistent atrial fibrillation and enlarged left atria?
Observational (n=718)
Does conduction system pacing combined with atrioventricular node ablation improve clinical outcomes compared to pulmonary vein isolation in patients with persistent atrial fibrillation and enlarged left atria?
In patients with persistent atrial fibrillation and enlarged left atria, an ablate and pace strategy using conduction system pacing showed similar clinical outcomes to pulmonary vein isolation over 40 months of follow-up.
Answers are grounded in this paper and cite their sources.
Similar outcomes after matching support clinical equipoise; leaves open need for randomized trials in persistent AF with enlarged atria.
BACKGROUND: Conduction system pacing (CSP) combined with atrioventricular node ablation (AVNA) is a feasible option for symptomatic atrial fibrillation (AF), but comparative studies with pulmonary vein isolation (PVI) are limited. OBJECTIVES: The aim of this study was to compare the clinical outcomes of CSP+AVNA and PVI in patients with persistent AF and a left atrial size. METHODS: This observational study included patients with persistent AF and a left atrial size >50 mm received PVI or CSP+AVNA (ablate and pace [AP]) from 2016 to 2022. Clinical outcomes, AF recurrence, and the composite endpoint of heart failure hospitalization and cardiac death were assessed. RESULTS: Out of 718 screened patients, 473 received PVI and 245 received AP. The AP strategy was associated with higher composite risk in univariate analysis (HR: 2.84; 95% CI: 1.79-4.50; P < 0.001) but not after multivariate adjustment (HR: 1.10; 95% CI: 0.54-2.23; P = 0.795). After 1:1 matching (n = 174), left ventricular ejection fraction improved similarly in both groups. Over an average 40 months' follow-up, the composite endpoint was similar between groups (propensity score matching [PSM]-AP: 14.9% vs PSM-PVI: 16.1%; P = 0.864). AF recurred in 54.0% in the PSM-PVI group and atrioventricular conduction recurred in 1.2% in the PSM-AP group. CONCLUSIONS: In this observational study, outcomes were numerically similar between PVI and AP in patients with persistent AF and enlarged left atria. Given the limited sample size and residual confounding, these results should be considered hypothesis-generating pending confirmation from randomized trials.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) conducted an observational in persistent atrial fibrillation and a left atrial size >50 mm (n=718). Conduction system pacing combined with atrioventricular node ablation vs. Pulmonary vein isolation was evaluated on composite endpoint of heart failure hospitalization and cardiac death (HR 1.10, 95% CI 0.54-2.23, p=0.864). Conduction system pacing with AV node ablation showed similar rates of heart failure hospitalization or cardiac death compared to pulmonary vein isolation in persistent AF.
Synapse has enriched 10 related papers. Consider them for comparative context: